Evidence map›Paper›PMID 36861863›Full record

ArticleThe Eurasian journal of medicine2023

Evaluating the Cytotoxic Effect of Melatonin and Oxyresveratrol on Dental Pulp Stem Cells.

Şeyma Keskin, Fatih Şengül, Büşra Şirin

Open access · diamondAbstract read
In one paragraph

Article in The Eurasian journal of medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Melatonin and the Dental Pulp: A Scoping Review.International endodontic journal · 2026
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Şeyma KeskinDepartment of Pedodontics, Atatürk University Faculty of Dentistry, Erzurum, Turkey.
Fatih ŞengülDepartment of Pedodontics, Atatürk University Faculty of Dentistry, Erzurum, Turkey.
Büşra ŞirinDepartment of Pharmacology, Atatürk University Faculty of Medicine, Erzurum, Turkey.
Atatürk University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveHypoxia in the pulpitis process, the use of bleaching agents, and resin-containing materials produce reactive oxygen species. Their damage to the pulp tissue can be eliminated by melatonin and oxyresveratrol. However, the cytotoxic effects of these antioxidants on dental pulp stem cells are not well known. The aim of this study was to observe the cytotoxic effects of melatonin and oxyresveratrol for 72 hours on dental pulp stem cells. MATERIALS AND

methodsHuman dental pulp stem cells obtained from the American Type Culture Collection were seeded on E-Plates®, and after 24 hours, 3 different doses of melatonin (100 pM, 100 nM, and 100 μM) and oxyresveratrol (10 μM, 25 μM, and 50 μM) were added. Real-time cell index data was acquired by using xCELLigence® device for 72 hours and inhibitor concentration (IC50) values of experimental groups were obtained. Analysis of covariance was used to compare the cell index values.

resultsIn comparison with the control group; oxyresveratrol 10 μM and melatonin 100 pM groups increased proliferation whereas oxyresveratrol 25 μM, oxyresveratrol 50 μM, and melatonin 100 μM groups induced cytotoxicity (P < .05). IC50 values at 24th, 48th, and 72th hours were 946 nM, 1220 nM, and 1243 nM for melatonin and 23 μM, 22.2 μM, and 22.5 μM for oxyresveratrol, respectively.

conclusionCytotoxicity of melatonin was higher than oxyresveratrol and they both increased dental pulp stem cells' proliferation at lower doses and induced cytotoxicity at higher doses.

Identifiers

PMID36861863
PMCPMC10081090
OpenAlexW4322758665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.